Home » News » Awards & Advancement » Genesis Biopharma names Bishop executive chairman

Genesis Biopharma names Bishop executive chairman

Friday, March 23, 2012

Genesis Biopharma, a biotechnology company developing targeted cancer immunotherapies, appointed Hans E. Bishop executive chairman of the company’s board of directors.

Bishop, who was promoted from director of Genesis Biopharma, most recently served as COO of Dendreon, with responsibility for a number of operational areas of the business including manufacturing and commercial operations. He has also held high positions in Bayer Healthcare and Chiron.

“The addition of Hans as our executive chair further enhances this dynamic team as he is a proven leader with an impressive track record of enhancing operational and financial results,” said Anthony Cataldo, former executive chairman.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!